Medifast Announces First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall St muted after Fed Chair Warsh's speech; AI rally cools
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil drifts lower as Hormuz flows balance slow progress in Iran diplomacy
- Dollar climbs after Warsh comments, poised for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
- BioNTech ends colorectal cancer mRNA therapy trial early
Medifast (MED) Tops Q1 EPS by 41c; Guides Q2 Lower
May 1, 2023 4:12 PM EDTMedifast (NYSE: MED) reported Q1 EPS of $3.67, $0.41 better than the analyst estimate of $3.26. Revenue for the quarter came in at $349 million versus the consensus estimate of $374.3 million.
GUIDANCE:
Medifast sees Q2 2023 EPS of $1.32-$1.44, versus the consensus of $2.82. Medifast sees Q2... More
